Increased plasma haemoglobin A1c (HbA1c) concentration and cardiovascular complications in obstructive sleep apnoea (OSA) patients with and without diabetes

B. Kazanecka, R. Plywaczewski, P. Bielen, L. Jonczak, P. Sliwinski, D. Gorecka (Warsaw, Poland)

Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Session: Systemic consequences of sleep-disordered breathing
Session type: E-Communication Session
Number: 2839
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Kazanecka, R. Plywaczewski, P. Bielen, L. Jonczak, P. Sliwinski, D. Gorecka (Warsaw, Poland). Increased plasma haemoglobin A1c (HbA1c) concentration and cardiovascular complications in obstructive sleep apnoea (OSA) patients with and without diabetes. Eur Respir J 2009; 34: Suppl. 53, 2839

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Association between plasma haemoglobin A1c (HbA1c) concentration and overnight desaturation in obstructive sleep apnoea (OSA) patients without diabetes
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013


Glycosylated hemoglobin (HbA1c) in adults with obstructive sleep apnea
Source: Eur Respir J 2007; 30: Suppl. 51, 492s
Year: 2007

Relationship between plasma NT-proBNP level and cardiovascular complications in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Year: 2010

Independent impact of obstructive sleep apnea severity on glycated haemoglobin in adults without diabetes
Source: Annual Congress 2012 - Diagnostics in OSA: from polygraphy to genetics and cancer
Year: 2012



Relations between cystatin C plasma concentration and cardiovascular complications in patients with obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Positive airway pressure treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients: Longitudinal data from the ESADA
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Cardiovascular diseases are responsible for increased plasma NT-proBNP level in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012


Association of fasting glucose and glycosylated haemoglobin levels with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008

C-reactive protein (CRP) and prevalence of cardiovascular diseases in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Association between arterial hypertension and impaired glucose tolerance (IGT) in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011

Plasma homocysteine (Hcy) levels in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea
Year: 2007


C-reactive protein (CRP) levels in obstructive sleep apnea (OSA) patients and relation to severity of OSA
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011


Relationship between NT-proBNP plasma level and nocturia in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea
Year: 2007


Effect of arterial hypertension, obesity and overnight desaturation on plasma uric acid concentration in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012


C-reactive protein (CRP) levels in obese patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 356s
Year: 2005

Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 330s
Year: 2004

Impact of obstructive sleep apnoea (OSA) on glucose metabolism
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007


Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009


Elevated leptin is associated with impaired glucose tolerance in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 573s
Year: 2006

Influence of body weight on plasma NT-proBNP in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2007 - Cardiovascular and respiratory control in obstructive sleep apnoea
Year: 2007